Advisory Commission on Childhood Vaccines, 74456 [2016-25875]
Download as PDF
74456
Federal Register / Vol. 81, No. 207 / Wednesday, October 26, 2016 / Notices
revision of Vaccine Information
Statements; and recommending to the
Director of the National Vaccine
Program research related to vaccine
injuries which should be conducted to
carry out the VICP.
On July 21, 2016, the ACCV charter
was renewed. Renewal of the ACCV
charter gives authorization for the
Commission to operate until July 21,
2018.
A copy of the ACCV charter is
available on the ACCV Web site at
https://www.hrsa.gov/
advisorycommittees/childhoodvaccines/
index.html. A copy of the charter also
can be obtained by accessing the FACA
database that is maintained by the
Committee Management Secretariat
under the General Services
Administration. The Web site address
for the FACA database is https://
www.facadatabase.gov/.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–25857 Filed 10–25–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
Advisory Commission on Childhood
Vaccines
Health Resources and Service
Administration, HHS.
ACTION: Notice of meeting.
AGENCY:
In accordance with section
10(a)(2) of the Federal Advisory
Committee Act (Public Law 92–463),
notice is hereby given that a meeting is
scheduled for the Advisory Commission
on Childhood Vaccines (ACCV). This
meeting will be open to the public.
Information about the ACCV and the
agenda for this meeting can be obtained
by accessing the following Web site:
https://www.hrsa.gov/
advisorycommittees/childhoodvaccines/
index.html.
DATES: The meeting will be held on
December 1 and 2, 2016, at 10:00 a.m.
EST.
ADDRESSES: This meeting will be held
via Adobe Connect Webinar. The public
can join the meeting by:
1. (Audio Portion) Calling the
conference phone number 800–779–
3561 and providing the following
information:
Leader Name: Dr. Narayan Nair.
Password: 8164763.
2. (Visual Portion) Connecting to the
ACCV Adobe Connect Pro Meeting
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:25 Oct 25, 2016
Jkt 241001
using the following URL: https://
hrsa.connectsolutions.com/accv/ (copy
and paste the link into your browser if
it does not work directly, and enter as
a guest). Participants should call and
connect 15 minutes prior to the meeting
in order for logistics to be set up. If you
have never attended an Adobe Connect
meeting, please test your connection
using the following URL: https://
hrsa.connectsolutions.com/common/
help/en/support/meeting_test.htm and
get a quick overview by following URL:
https://www.adobe.com/go/connectpro_
overview.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the ACCV should contact
Annie Herzog, Program Analyst,
Division of Injury Compensation
Programs (DICP), Health Resources and
Services Administration in one of three
ways: (1) Send a request to the following
address: Annie Herzog, Program
Analyst, DICP, Health Resources and
Services Administration, 5600 Fishers
Lane, 08N146B, Rockville, Maryland
20857; (2) call (301) 443–6593; or (3)
send an email to aherzog@hrsa.gov.
At this time the meeting is scheduled
to be held over 2 days via conference
call and Adobe Connect webinar;
however, meeting times and locations
could change. For the latest information
regarding meeting start time and
location, please check the ACCV Web
site: https://www.hrsa.gov/
advisorycommittees/childhoodvaccines/
index.html.
SUPPLEMENTARY INFORMATION: The ACCV
was established by section 2119 of the
Public Health Service Act (the Act) (42
U.S.C. 300aa–19), as enacted by Public
Law (Pub. L.) 99–660, and as
subsequently amended, and advises the
Secretary of Health and Human Services
(the Secretary) on issues related to
implementation of the National Vaccine
Injury Compensation Program (VICP).
Other activities of ACCV include:
Recommending changes to the Vaccine
Injury Table at its own initiative or as
the result of the filing of a petition;
advising the Secretary in implementing
section 2127 of the Act regarding the
need for childhood vaccination
products that result in fewer or no
significant adverse reactions; surveying
federal, state, and local programs and
activities related to gathering
information on injuries associated with
the administration of childhood
vaccines, including the adverse reaction
reporting requirements of section
2125(b) of the Act; advising the
Secretary on the methods of obtaining,
compiling, publishing, and using
credible data related to the frequency
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
and severity of adverse reactions
associated with childhood vaccines;
consulting on the development or
revision of Vaccine Information
Statements; and recommending to the
Director of the National Vaccine
Program research related to vaccine
injuries which should be conducted to
carry out VICP.
The agenda items for the December
2016 meeting will include, but are not
limited to, updates from the Division of
Injury Compensation Programs (DICP),
Department of Justice (DOJ), National
Vaccine Program Office (NVPO),
Immunization Safety Office (Centers for
Disease Control and Prevention),
National Institute of Allergy and
Infectious Diseases (National Institutes
of Health) and Center for Biologics,
Evaluation and Research (Food and
Drug Administration). A draft agenda
and additional meeting materials will be
posted on the ACCV Web site (https://
www.hrsa.gov/advisorycommittees/
childhoodvaccines/) prior to
the meeting. Agenda items are subject to
change as priorities dictate.
Members of the public will have the
opportunity to provide comments. Oral
comments will be honored in the order
they are requested and may be limited
as time allows. Requests to make oral
comments or provide written comments
to the ACCV should be sent to Annie
Herzog using the address and phone
number above by November 29, 2016.
Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify Annie
Herzog, using the address and phone
number above at least 10 days prior to
the meeting.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–25875 Filed 10–25–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Renewal of Charters for Certain
Federal Advisory Committees
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, as amended (5
U.S.C. App), the U.S. Department of
Health and Human Services is hereby
announcing that the charters have been
renewed for the following federal
advisory committees for which Office of
SUMMARY:
E:\FR\FM\26OCN1.SGM
26OCN1
Agencies
[Federal Register Volume 81, Number 207 (Wednesday, October 26, 2016)]
[Notices]
[Page 74456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25875]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration
Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Service Administration, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463), notice is hereby given that a
meeting is scheduled for the Advisory Commission on Childhood Vaccines
(ACCV). This meeting will be open to the public. Information about the
ACCV and the agenda for this meeting can be obtained by accessing the
following Web site: https://www.hrsa.gov/advisorycommittees/childhoodvaccines/.
DATES: The meeting will be held on December 1 and 2, 2016, at 10:00
a.m. EST.
ADDRESSES: This meeting will be held via Adobe Connect Webinar. The
public can join the meeting by:
1. (Audio Portion) Calling the conference phone number 800-779-3561
and providing the following information:
Leader Name: Dr. Narayan Nair.
Password: 8164763.
2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro
Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work
directly, and enter as a guest). Participants should call and connect
15 minutes prior to the meeting in order for logistics to be set up. If
you have never attended an Adobe Connect meeting, please test your
connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by
following URL: https://www.adobe.com/go/connectpro_overview.
FOR FURTHER INFORMATION CONTACT: Anyone requesting information
regarding the ACCV should contact Annie Herzog, Program Analyst,
Division of Injury Compensation Programs (DICP), Health Resources and
Services Administration in one of three ways: (1) Send a request to the
following address: Annie Herzog, Program Analyst, DICP, Health
Resources and Services Administration, 5600 Fishers Lane, 08N146B,
Rockville, Maryland 20857; (2) call (301) 443-6593; or (3) send an
email to aherzog@hrsa.gov.
At this time the meeting is scheduled to be held over 2 days via
conference call and Adobe Connect webinar; however, meeting times and
locations could change. For the latest information regarding meeting
start time and location, please check the ACCV Web site: https://www.hrsa.gov/advisorycommittees/childhoodvaccines/.
SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of
the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as
enacted by Public Law (Pub. L.) 99-660, and as subsequently amended,
and advises the Secretary of Health and Human Services (the Secretary)
on issues related to implementation of the National Vaccine Injury
Compensation Program (VICP).
Other activities of ACCV include: Recommending changes to the
Vaccine Injury Table at its own initiative or as the result of the
filing of a petition; advising the Secretary in implementing section
2127 of the Act regarding the need for childhood vaccination products
that result in fewer or no significant adverse reactions; surveying
federal, state, and local programs and activities related to gathering
information on injuries associated with the administration of childhood
vaccines, including the adverse reaction reporting requirements of
section 2125(b) of the Act; advising the Secretary on the methods of
obtaining, compiling, publishing, and using credible data related to
the frequency and severity of adverse reactions associated with
childhood vaccines; consulting on the development or revision of
Vaccine Information Statements; and recommending to the Director of the
National Vaccine Program research related to vaccine injuries which
should be conducted to carry out VICP.
The agenda items for the December 2016 meeting will include, but
are not limited to, updates from the Division of Injury Compensation
Programs (DICP), Department of Justice (DOJ), National Vaccine Program
Office (NVPO), Immunization Safety Office (Centers for Disease Control
and Prevention), National Institute of Allergy and Infectious Diseases
(National Institutes of Health) and Center for Biologics, Evaluation
and Research (Food and Drug Administration). A draft agenda and
additional meeting materials will be posted on the ACCV Web site
(https://www.hrsa.gov/advisorycommittees/childhoodvaccines/)
prior to the meeting. Agenda items are subject to change as priorities
dictate.
Members of the public will have the opportunity to provide
comments. Oral comments will be honored in the order they are requested
and may be limited as time allows. Requests to make oral comments or
provide written comments to the ACCV should be sent to Annie Herzog
using the address and phone number above by November 29, 2016.
Individuals who need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify Annie
Herzog, using the address and phone number above at least 10 days prior
to the meeting.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-25875 Filed 10-25-16; 8:45 am]
BILLING CODE 4165-15-P